Surgery Partners issued a press release on November 10, 2025, announcing its financial results for the third quarter of 2025 and held an earnings call to discuss the same. The Company lowered its full-year revenue guidance to a range of $3.275 billion to $3.3 billion, and its adjusted EBITDA guidance to a range of $535 million to $540 million. Surgery Partners' management attributed the guidance revision to timing delays in capital deployment, lost earnings from ambulatory surgical center divestitures, and a cautious stance on commercial payer mix and volume in the fourth quarter.
Following this news, Surgery Partners' stock price fell over 25% on November 10, 2025.
To receive more information, please fill out the form.
